Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3

CONTEXT: Molecular testing has improved risk stratification and increased nonoperative management for patients with indeterminate thyroid nodules, but data on the long-term outcomes of current molecular tests Afirma Gene Sequencing Classifier (GSC) and Thyroseq v3 are limited. OBJECTIVE: To determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Na Eun, Raghunathan, Rajam S, Hughes, Elena G, Longstaff, Xochitl R, Tseng, Chi-Hong, Li, Shanpeng, Cheung, Dianne S, Gofnung, Yaroslav A, Famini, Pouyan, Wu, James X, Yeh, Michael W, Livhits, Masha J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438873/
https://www.ncbi.nlm.nih.gov/pubmed/36995878
http://dx.doi.org/10.1210/clinem/dgad181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438873/
https://www.ncbi.nlm.nih.gov/pubmed/36995878
http://dx.doi.org/10.1210/clinem/dgad181

Ejemplares similares